Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib)…
Month: September 2015
Post diagnosis aspirin improves survival in all gastrointestinal cancers, study suggests
Aspirin improves survival in patients with tumors situated throughout the gastrointestinal tract, results from a…
Atezolizumab set to change refractory lung cancer treatment
Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according…
Everolimus improves progression-free survival for patients with advanced, nonfuctional neuroendocrine tumors
In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of…
Differences between tumors of younger and older colorectal cancer patients
Tumors in younger colorectal cancer patients may be molecularly distinct from those of older patients,…
Treatment of elderly breast cancer patients varies between different European countries
The largest international comparison of the treatment of elderly patients with breast cancer has shown…
Genetic screening of brain metastases could reveal new targets for treatment
Unravelling the genetic sequences of cancer that has spread to the brain could offer unexpected…
Rare cancer responds unusually well to new treatment: Results from the NETTER-1 trial
Results from a multi-center randomized international trial of an innovative treatment show a marked improvement…
Results of international trial show promise in rare, difficult to treat cancer: Results from the RADIANT-4 trial
An international team of researchers has shown that the use of the mTOR inhibitor, everolimus,…
Lung cancer survival rates improve with CT scan follow-up
Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a…